Status:
COMPLETED
Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance
Lead Sponsor:
University of Toronto
Collaborating Sponsors:
University of Colorado, Boulder
Kaiser Permanente
Conditions:
Major Depressive Disorder, Recurrent, in Remission
Depressive Symptoms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Many patients report residual depressive symptoms despite seemingly successful treatment. With the investigators' previous funding, we developed - Mindful Mood Balance - an online treatment that targe...
Detailed Description
Residual depressive symptoms (RDS) following remission of major depressive disorder (MDD) are reported by 80-90% of adults receiving first-line antidepressant pharmacotherapy and carry an elevated ris...
Eligibility Criteria
Inclusion
- Patients with a PHQ-9 score between 5 and 9
- At least one prior episode of MDD
Exclusion
- presence of schizophrenia or current psychosis, organic mental disorder or pervasive developmental delay
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT02190968
Start Date
March 1 2015
End Date
November 1 2018
Last Update
January 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Institute for Health Research
Denver, Colorado, United States, 80237-8066